Advertisement

Infection

, Volume 41, Issue 1, pp 167–174 | Cite as

Infective endocarditis in congenital heart disease: a frequent community-acquired complication

  • J. Fortún
  • T. Centella
  • P. Martín-Dávila
  • M. J. Lamas
  • C. Pérez-Caballero
  • L. Fernández-Pineda
  • E. Otheo
  • J. Cobo
  • E. Navas
  • V. Pintado
  • E. Loza
  • S. Moreno
Clinical and Epidemiological Study

Abstract

Background

Infective endocarditis (IE) is a severe complication in patients with congenital heart disease (CHD). Epidemiology, etiology, and outcome in this group are different to those of patients with acquired heart disease.

Methods

We reviewed all cases of proven and probable IE (Duke’s criteria) diagnosed in our center during the last two decades.

Results

We observed 45 cases of IE in patients with CHD (age range 8 months to 35 years); these represented 5.5 % of all the episodes of IE in our institution during the study period. The most frequent CHD were ventricular septal defect (31 %), tetralogy of Fallot (19 %), and atrioventricular septal defect (11 %). Twenty cases of IE (44 %) were recorded in patients with non-corrected native-valve CHD. Of the 24 patients with prosthetic-valve IE, post-operative acquisition during the first 6 months was confirmed in 11 patients (range 4–110 days). IE was community-acquired in 62 % of cases. Streptococcus spp. were the most frequent etiologic agents (33 %), followed by Staphylococcus spp. (32 %). Surgery was required to treat IE in 47 % of patients (52 % in prosthetic-valve IE and 41 % in native-valve IE, p = ns). In comparison to native-valve IE, prosthetic-valve IE was significantly more nosocomial-acquired (61 vs. 14 %, p = 0.002), presented a higher heart failure rate at diagnosis (39 vs. 9 %, p = 0.035), and developed more breakthrough bacteremia episodes (19 vs. 0 %, p = 0.048). Global mortality was 24 % (75 % in patients with prosthetic-valve IE who required surgery and 0 % in patients with native-valve IE who required surgery, p = 0.001). Multivariate analysis excluding breakthrough bacteremia (100 % mortality in this condition) confirmed that nosocomial IE [odds ratio (OR), 23.7; 95 % confidence interval (CI), 2.3–239.9] and the presence of heart failure at diagnosis of IE (OR, 25.9; 95 % CI, 2.5–269.6) were independent factors associated with mortality.

Conclusion

Half of all cases of IE in patients with CHD occurred in patients with non-corrected native-valve CHD and two-thirds were community-acquired. Streptococcus spp. were the most frequent etiological agents. Patients with prosthetic-valve IE present a worse outcome, especially those requiring surgery. Breakthrough bacteremia, nosocomial IE, and heart failure are independent factors of mortality in patients with CHD presenting IE.

Keywords

Endocarditis Congenital heart disease Prosthetic valve 

Notes

Conflict of interest

The authors declare no conflicts of interest.

Ethical standard

The authors of this manuscript have certified that they comply with the Principles of Ethical Publishing in Infection.

References

  1. 1.
    Yoshinaga M, Niwa K, Niwa A, Ishiwada N, Takahashi H, Echigo S, et al. Risk factors for in-hospital mortality during infective endocarditis in patients with congenital heart disease. Am J Cardiol. 2008;101:114–8.PubMedCrossRefGoogle Scholar
  2. 2.
    Dore A, Glancy DL, Stone S, Menashe VD, Somerville J. Cardiac surgery for grown-up congenital heart patients: survey of 307 consecutive operations from 1991 to 1994. Am J Cardiol. 1997;80:906–13.PubMedCrossRefGoogle Scholar
  3. 3.
    Wren C, O’Sullivan JJ. Survival with congenital heart disease and need for follow up in adult life. Heart. 2001;85:438–43.PubMedCrossRefGoogle Scholar
  4. 4.
    Li W, Somerville J. Infective endocarditis in the grown-up congenital heart (GUCH) population. Eur Heart J. 1998;19:166–73.PubMedCrossRefGoogle Scholar
  5. 5.
    Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. J Am Dent Assoc. 2007;138(6):739–45, 747–60.PubMedGoogle Scholar
  6. 6.
    Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30:2369–413.PubMedCrossRefGoogle Scholar
  7. 7.
    Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA. 1997;277:1794–801.PubMedCrossRefGoogle Scholar
  8. 8.
    Day MD, Gauvreau K, Shulman S, Newburger JW. Characteristics of children hospitalized with infective endocarditis. Circulation. 2009;119:865–70.PubMedCrossRefGoogle Scholar
  9. 9.
    van der Meer JT, Thompson J, Valkenburg HA, Michel MF. Epidemiology of bacterial endocarditis in the Netherlands. II. Antecedent procedures and use of prophylaxis. Arch Intern Med. 1992;152:1869–73.PubMedCrossRefGoogle Scholar
  10. 10.
    McKinsey DS, Ratts TE, Bisno AL. Underlying cardiac lesions in adults with infective endocarditis. The changing spectrum. Am J Med. 1987;82:681–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Weber R, Berger C, Balmer C, Kretschmar O, Bauersfeld U, Pretre R, et al. Interventions using foreign material to treat congenital heart disease in children increase the risk for infective endocarditis. Pediatr Infect Dis J. 2008;27:544–50.PubMedCrossRefGoogle Scholar
  12. 12.
    Di Filippo S, Delahaye F, Semiond B, Celard M, Henaine R, Ninet J, et al. Current patterns of infective endocarditis in congenital heart disease. Heart. 2006;92:1490–5.PubMedCrossRefGoogle Scholar
  13. 13.
    Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Tissières P, Gervaix A, Beghetti M, Jaeggi ET. Value and limitations of the von Reyn, Duke, and modified Duke criteria for the diagnosis of infective endocarditis in children. Pediatrics. 2003;112:e467.PubMedCrossRefGoogle Scholar
  15. 15.
    de Gevigney G, Pop C, Delahaye JP. The risk of infective endocarditis after cardiac surgical and interventional procedures. Eur Heart J. 1995;16(Suppl B):7–14.PubMedCrossRefGoogle Scholar
  16. 16.
    Morris CD, Reller MD, Menashe VD. Thirty-year incidence of infective endocarditis after surgery for congenital heart defect. JAMA. 1998;279:599–603.PubMedCrossRefGoogle Scholar
  17. 17.
    Siddiqui BK, Tariq M, Jadoon A, Murtaza G, Syed A, Bilal Abid M, et al. Infective endocarditis in patients with congenitally malformed hearts: characterization of the syndrome in a developing country. Cardiol Young. 2007;17:623–30.PubMedCrossRefGoogle Scholar
  18. 18.
    Ferrieri P, Gewitz MH, Gerber MA, Newburger JW, Dajani AS, Shulman ST, et al. Unique features of infective endocarditis in childhood. Circulation. 2002;105:2115–26.PubMedCrossRefGoogle Scholar
  19. 19.
    Kaplan EL, Rich H, Gersony W, Manning J. A collaborative study of infective endocarditis in the 1970s. Emphasis on infections in patients who have undergone cardiovascular surgery. Circulation. 1979;59:327–35.PubMedCrossRefGoogle Scholar
  20. 20.
    Knirsch W, Haas NA, Uhlemann F, Dietz K, Lange PE. Clinical course and complications of infective endocarditis in patients growing up with congenital heart disease. Int J Cardiol. 2005;101:285–91.PubMedCrossRefGoogle Scholar
  21. 21.
    Ishiwada N, Niwa K, Tateno S, Yoshinaga M, Terai M, Nakazawa M; for The Japanese Society of Pediatric Cardiology and Cardiac Surgery Joint Working Groups for Guidelines for Prophylaxis, Diagnosis and Management of Infective Endocarditis in Patients With Congenital Heart Disease. Causative organism influences clinical profile and outcome of infective endocarditis in pediatric patients and adults with congenital heart disease. Circ J. 2005;69:1266–70.PubMedCrossRefGoogle Scholar
  22. 22.
    Dyson C, Barnes RA, Harrison GAJ. Infective endocarditis: an epidemiological review of 128 episodes. J Infect. 1999;38:87–93.PubMedCrossRefGoogle Scholar
  23. 23.
    Marom D, Levy I, Gutwein O, Birk E, Ashkenazi S. Healthcare-associated versus community-associated infective endocarditis in children. Pediatr Infect Dis J. 2011;30:585–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Menon T, Naveen Kumar V. Catonella morbi as a cause of native valve endocarditis in Chennai, India. Infection. 2012 Feb 25. [Epub ahead of print].Google Scholar
  25. 25.
    Suárez-García I, Sánchez-García A, Soler L, Malmierca E, Gómez-Cerezo J. Lactobacillus jensenii bacteremia and endocarditis after dilatation and curettage: case report and literature review. Infection. 2012;40:219–22.PubMedCrossRefGoogle Scholar
  26. 26.
    Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC, et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med. 2012;366:2466–73.PubMedCrossRefGoogle Scholar
  27. 27.
    Karl T, Wensley D, Stark J, de Leval M, Rees P, Taylor JF. Infective endocarditis in children with congenital heart disease: comparison of selected features in patients with surgical correction or palliation and those without. Br Heart J. 1987;58:57–65.PubMedCrossRefGoogle Scholar
  28. 28.
    Rosenthal LB, Feja KN, Levasseur SM, Alba LR, Gersony W, Saiman L. The changing epidemiology of pediatric endocarditis at a children’s hospital over seven decades. Pediatr Cardiol. 2010;31:813–20.PubMedCrossRefGoogle Scholar
  29. 29.
    Leone S, Ravasio V, Durante-Mangoni E, Crapis M, Carosi G, Scotton PG, Barzaghi N, Falcone M, Chinello P, Pasticci MB, Grossi P, Utili R, Viale P, Rizzi M, Suter F. Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian study on endocarditis. Infection. 2012 Jun 19. [Epub ahead of print].Google Scholar
  30. 30.
    Bouza E, Menasalvas A, Muñoz P, Vasallo FJ, Del Mar Moreno M, García Fernández MA. Infective endocarditis—a prospective study at the end of the twentieth century: new predisposing conditions, new etiologic agents, and still a high mortality. Medicine (Baltimore). 2001;80:298–307.CrossRefGoogle Scholar
  31. 31.
    Niwa K, Nakazawa M, Miyatake K, Tateno S, Yoshinaga M; Japanese Circulation Society (JCS) Joint Working Groups for Guidelines for Management of Infective Endocarditis; Japanese Society of Pediatric Cardiology and Cardiac Surgery Joint Working Groups for Guidelines for Prophylaxix, Diagnosis and Management of Infective Endocarditis in Patients with Congenital Heart Disease. Survey of prophylaxis and management of infective endocarditis in patients with congenital heart disease: Japanese nationwide survey. Circ J. 2003;67:585–91.PubMedCrossRefGoogle Scholar
  32. 32.
    Bayer AS, Bolger AF, Taubert KA, Wilson W, Steckelberg J, Karchmer AW, et al. Diagnosis and management of infective endocarditis and its complications. Circulation. 1998;98:2936–48.PubMedCrossRefGoogle Scholar
  33. 33.
    Saiman L, Prince A, Gersony WM. Pediatric infective endocarditis in the modern era. J Pediatr. 1993;122:847–53.PubMedCrossRefGoogle Scholar
  34. 34.
    Miro JM, Anguera I, Cabell CH, Chen AY, Stafford JA, Corey GR, et al; International Collaboration on Endocarditis Merged Database Study Group. Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis. 2005;41:507–14.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • J. Fortún
    • 1
  • T. Centella
    • 2
  • P. Martín-Dávila
    • 1
  • M. J. Lamas
    • 2
  • C. Pérez-Caballero
    • 3
  • L. Fernández-Pineda
    • 4
  • E. Otheo
    • 5
  • J. Cobo
    • 1
  • E. Navas
    • 1
  • V. Pintado
    • 1
  • E. Loza
    • 6
  • S. Moreno
    • 1
  1. 1.Infectious Diseases Department, Servicio de Enfermedades InfecciosasHospital Ramón y CajalMadridSpain
  2. 2.Pediatric Cardiac Surgery DepartmentHospital Ramón y CajalMadridSpain
  3. 3.Pediatric Intensive Care UnitHospital Ramón y CajalMadridSpain
  4. 4.Pediatric Cardiology DepartmentHospital Ramón y CajalMadridSpain
  5. 5.Pediatric DepartmentHospital Ramón y CajalMadridSpain
  6. 6.Microbiology DepartmentHospital Ramón y CajalMadridSpain

Personalised recommendations